Clinical Trials Browser

Phase 3 × Unknown × Gefitinib × Clear all

NCT03849768 2023-01-20

A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients

Phase 3 Unknown

429 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT01951469 2022-03-08

Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01405079 2020-02-18

ADJUVANT

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04028778 2019-11-08

FL-ALTER

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02929693 2019-04-11

Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma

Phase 3 Unknown

Neoplasms

NCT03856697 2019-02-27

Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

Phase 3 Unknown

Advanced Non-small Cell Lung Cancer

NCT03656393 2018-09-04

RCTACSCNSCLC

Phase 3 Unknown

NSCLC

NCT02714010 2017-10-27

EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02824458 2016-07-07

A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations

Phase 3 Unknown

EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors

NCT00006048 2013-12-19

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00006049 2013-12-19

ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00955695 2013-08-02

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer

Phase 3 Unknown

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01158170 2010-07-08

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01066195 2010-02-10

Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung